NON-SMALL CELL LUNG CANCER STAGE III

This adverse event was reported 34 times

These drugs are most commonly taken by patients reporting NON-SMALL CELL LUNG CANCER STAGE III:

# Drug Count
0 OMEPRAZOLE MAGNESIUM 10
1 OMEPRAZOLE 5
2 ACETAMINOPHEN 4
3 ASPIRIN 4
4 ASPIRIN 325 MG 4
5 ASPIRIN 81 MG 4
6 DURVALUMAB 4
7 GABAPENTIN 4
8 INTERFERON BETA-1A 4
9 METFORMIN 4
See all common drugs associated with NON-SMALL CELL LUNG CANCER STAGE III

NON-SMALL CELL LUNG CANCER STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGFILGRASTIM-CBQV 1 0.0007
1 IMIQUIMOD 1 0.0004
2 DURVALUMAB 4 0.0002
3 ACLIDINIUM BROMIDE 1 0.0002
4 PENTOSAN POLYSULFATE SODIUM 1 0.0001
5 NIACIN 1 0.0001
6 OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN 1 0.0001
7 DILTIAZEM HYDROCHLORIDE 2 0.0001
8 FLUTICASONE PROPIONATE NASAL 2 0.0001
9 BIOTIN 2 0.0001
See all drugs enriched for association with NON-SMALL CELL LUNG CANCER STAGE III